Dendreon

*Provenge to Survive Dendreon’s Bankruptcy – Welcome Valeant to the Prostate Cancer Community

Dendreon, the manufacture of the only FDA approved immunologic therapy for prostate cancer had been burdened with significant debt. The debt came from their R&D of Provenge, their seeking FDA approval and the construction of three manufacturing plants to produce the treatment. Sadly, the company was unable to get its income ahead of its debt [...]

By Malecare|2015-02-11T09:33:37-05:00February 11th, 2015|Advanced Prostate Cancer, immunotherapy, Provenge, Uncategorized, vaccines|2 Comments

Dendreon Files for Chapter 11 Voluntary Bankruptcy Reorganization – Production Continues

It was announced this morning that Dendreon (the manufactures of Provenge) has filed for voluntary Chapter 11 Bankruptcy. After having spoken with a representative at Dendreon I have learned that the company has been in negotiations with its creditors and agreed to voluntarily file for financial reorganization. The agreement that Dendreon has reached with their [...]

By Malecare|2021-02-17T10:57:53-05:00November 10th, 2014|Advanced Prostate Cancer, Drugs & Treatments, European Union, General Information, Provenge, Uncategorized